Navigation Links
Acromegaly in Medical News

Indevus Pharmaceuticals Announces Definitive Merger Agreement With Endo Pharmaceuticals

... and the octreotide implant (in development for acromegaly and carcinoid syndrome), two of Indevus' primary ... FDA for marketing and sale for the treatment of acromegaly or carcinoid syndrome. The tender offer is ... pathogens, the octreotide implant for acromegaly and carcinoid syndrome, and pagoclone for ...

Indevus Pharmaceuticals Announces First Quarter Fiscal 2009 Financial Results

... Endo in the future upon achievement of certain milestones related to NEBIDO(R) (in development for hypogonadism) and octreotide (in development for acromegaly and carcinoid syndrome), two of the Company's primary product candidates. The acquisition will be effected by means of a tender offer for all the ...

Endo Pharmaceuticals to Acquire Indevus Pharmaceuticals

... NEBIDO(R) for hypogonadism, PRO 2000 for the prevention of infection by HIV and other sexually-transmitted pathogens, the octreotide implant for acromegaly and carcinoid syndrome, and pagoclone for stuttering. About Endo Pharmaceuticals Endo Pharmaceuticals is a specialty pharmaceutical ...

Options Improving for Patients With Acromegaly and Gigantism

... Medicine. “Despite the improvements, acromegaly remains a very challenging and very complex ... of our support groups.” Nearly all cases of acromegaly are caused by tumors of the pituitary gland. More than 90 percent of patients with acromegaly have a slow-growing type of tumor that is found ...

Look younger with HGH!!

... Mr Prakash said: "Taken in low doses, research shows that human growth hormone is as safe as vitamin C”. Long-term usage can also result in acromegaly — a condition that causes oily skin, a large tongue and protruding forehead. Dr Cooper said: “Sufferers sometimes have a huge chin, huge ...
Acromegaly in Medical Technology

FDA Accepts Complete Response Submission to New Drug Application for NEBIDO(R)

... NEBIDO(R) for hypogonadism, PRO 2000 for the prevention of infection by HIV and other sexually-transmitted pathogens, the octreotide implant for acromegaly and carcinoid syndrome, and pagoclone for stuttering. Safe Harbor Statement This press release contains forward-looking statements ...

Indevus Pharmaceuticals Announces PRO 2000 Found to Show Promise in Large HIV Prevention Study

... NEBIDO(R) for hypogonadism, PRO 2000 for the prevention of infection by HIV and other sexually-transmitted pathogens, the octreotide implant for acromegaly and carcinoid syndrome, and pagoclone for stuttering. PRO 2000 PRO 2000 (a naphthalene sulfonate polymer) is under development as a ...

Indevus Announces Agreement With Teva to Develop Pagoclone for the Treatment of Stuttering

... for male hypogonadism, PRO 2000 for the prevention of infection by HIV and other sexually-transmitted pathogens, and the octreotide implant for acromegaly and carcinoid syndrome. About Pagoclone Pagoclone is a novel, non-benzodiazepine, selective GABA-A receptor agonist. In clinical studies in ...

ATL/TV1102 Trial Results Presented at World Congress on Treatment and Research in Multiple Sclerosis

... is a second-generation antisense drug designed to lower blood IGF-I levels and is entering pre-clinical development as a potential treatment for acromegaly and vision disorders. ATL/TV1102 (inhaled) is at the pre-clinical research stage as a potential treatment for asthma. ATL1101 is a second-generation ...

Indevus Pharmaceuticals Reports Positive Results of Phase II Octreotide Implant Trial

... patented Hydron technology utilized in the Company's currently approved and marketed products SUPPRELIN(R) LA and VANTAS(R). About Acromegaly acromegaly is a chronic hormonal disorder that occurs when a pituitary tumor produces excess growth hormone, or GH. It most commonly affect middle- aged adults, ...

Ambrilia Highlights Encouraging Data for its HIV Integrase Inhibitor Program and Recent Developments at Annual Meeting

... partnering and product development strategies to move forward with PCK3145. - The pivotal Phase III clinical trial in Europe with Octreotide in acromegaly patients was initiated in February and Ambrilia obtained an IND with its U.S. licensing partner, Mallinckrodt, to conduct a pivotal Phase III ...
Acromegaly in Medical Products

Free IGF-I IRMA Test

Description:... many of the actions of GH [6]. In GH deficiency, malnutrition [4] and GH-receptor deficiency [7], serum IGF-I levels are low. Conversely, in acromegaly (GH excess) serum IGF-I levels are elevated [4,6]. Measurement of IGF-I levels in serum is a useful diagnostic test for the clinical evaluation of ...
Company:Diagnostic Systems Laboratories, Inc.

IGF-I IRMA Test (With Extraction)

Description:... many of the actions of GH [6]. In GH deficiency, malnutrition [4] and GH-receptor deficiency [7], serum IGF-I levels are low. Conversely, in acromegaly (GH excess) serum IGF-I levels are elevated [4,6]. Measurement of IGF-I levels in serum is a useful diagnostic test for the clinical evaluation of ...
Company:Diagnostic Systems Laboratories, Inc.

IGF-I ELISA Test (With Extraction)

Description:... many of the actions of GH [6]. In GH deficiency, malnutrition [4] and GH-receptor deficiency [7], serum IGF-I levels are low. Conversely, in acromegaly (GH excess) serum IGF-I levels are elevated [4,6]. Measurement of IGF-I levels in serum is a useful diagnostic test for the clinical evaluation of ...
Company:Diagnostic Systems Laboratories, Inc.

IGF-I IRMA Test (Non-Extraction)

Description:... many of the actions of GH [6]. In GH deficiency, malnutrition [4] and GH-receptor deficiency [7], serum IGF-I levels are low. Conversely, in acromegaly (GH excess) serum IGF-I levels are elevated [4,6]. Measurement of IGF-I levels in serum is a useful diagnostic test for the clinical evaluation of ...
Company:Diagnostic Systems Laboratories, Inc.

IGF-I ELISA Test (Non-Extraction)

Description:... many of the actions of GH [6]. In GH deficiency, malnutrition [4] and GH-receptor deficiency [7], serum IGF-I levels are low. Conversely, in acromegaly (GH excess) serum IGF-I levels are elevated [4,6]. Measurement of IGF-I levels in serum is a useful diagnostic test for the clinical evaluation of ...
Company:Diagnostic Systems Laboratories, Inc.

Free IGF-I ELISA Test

Description:... many of the actions of GH [6]. In GH deficiency, malnutrition [4] and GH-receptor deficiency [7], serum IGF-I levels are low. Conversely, in acromegaly (GH excess) serum IGF-I levels are elevated [4,6]. Measurement of IGF-I levels in serum is a useful diagnostic test for the clinical evaluation of ...
Company:Diagnostic Systems Laboratories, Inc.

More>>

Acromegaly in Medical Definition

Pathology

... Hypoparathyroidism ( Pseudohypoparathyroidism ) - Hyperparathyroidism ( Primary , Secondary , Tertiary ) Pituitary hyperfunction ( acromegaly , Hyperprolactinaemia , Syndrome of inappropriate antidiuretic hormone ) - Hypopituitarism ( Sheehan's syndrome , Kallmann syndrome , Simmonds' ...
Acromegaly in Medical Dictionary

Acromegaly

... acromegaly : The Growth Disease Summary & Participants ... it's on fashion runways or basketball courts. acromegaly Overview acromegaly is a serious condition that occurs when the body ...

Gigantism

... increased blood supply to that part. 2. acromegaly and gigantism Definition acromegaly is a disorder in which the abnormal release of a ... for pituitary tumours to occur in adulthood. acromegaly can occur in children. When it does, it is ...

Growth hormone

... tumor s make growth hormone . Too much growth hormone can cause acromegaly (the hands, feet, and face are larger than normal) or gigantism (the ... , rare cancer s, or excess production of growth hormone ( acromegaly ). ...

Acoustic

... of the most common types of brain tumors . They affect approximately 1 out of 100,000 people per year. Acoustic neuroma Acoustic trauma acromegaly Acute (sub acute ) subdural hematoma Amyotrophic lateral sclerosis Arteriovenous malformation (cerebral) Benign positional vertigo ...

Acoustic neuroma

... one of the most common types of brain tumors . They affect approximately 1 out of 100,000 people per year. Acoustic neuroma Acoustic trauma acromegaly Acute (sub acute ) subdural hematoma Amyotrophic lateral sclerosis Arteriovenous malformation (cerebral) Benign positional vertigo ...

Acoustic trauma

... ( Carpal Tunnel Syndrome ) Noise -Induced Hearing Loss (Occupational Hearing Loss ) Occupational Hearing Loss ... Acoustic trauma acromegaly Acute (sub acute ) subdural hematoma Amyotrophic lateral sclerosis Arteriovenous malformation (cerebral) Benign positional vertigo ...

Acrodysostosis

... Dr Trisha Macnair Acrodysostosis is a rare inherited condition that affects the development of bones. Acro dysplasia ( Acrodysostosis ) acromegaly ACTH ACTH (Cortrosyn) Stimulation Test ACTH Suppression Test (Dexamethasone Suppression Test) ... ...

Carcinoid syndrome

... to 283 ng/ml. Elevations are seen in carcinoid syndrome . Indications: (1) reduction of growth hormone and IGF-1 ( insulin growth factor) in acromegaly ; (2) suppression of severe diarrhea and flushing associated with malignant carcinoid syndrome ; ... Carcinoembryonic Antigen (CEA) ...

Colon cancer screening

... Fine for Lobular Breast Cancer s Screening Combo May Improve Colorectal Cancer ... Colon Cancer Screening : An Easy Way to Save Your Life acromegaly : The Growth Disease What is BPH ? Most medical experts recommend colon cancer screening beginning at age 50 for people who have an average ...

Edema

... small arteries; swelling in the brain (cerebral o edema ), ... On shaking hands, a patient with extremely large hands may have the disease acromegaly . Swollen ankles may indicate edema due to a kidney or a heart problem. The medical and dental history should be reviewed before the ...

More>>

Acromegaly in Biological Technology

Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results

... of PRO 2000 -- Phase III Clinical Trial of Octreotide Implant for acromegaly Initiated Business Development -- Licensing of European Rights ... HIV and other sexually-transmitted pathogens, the octreotide implant for acromegaly and carcinoid syndrome, and pagoclone for stuttering. About ...

Indevus Pharmaceuticals Announces Release of 2008 Annual Report

... NEBIDO(R) for hypogonadism, PRO 2000 for the prevention of infection by HIV and other sexually-transmitted pathogens, the octreotide implant for acromegaly and carcinoid syndrome, and pagoclone for stuttering. Contact: Michael W. Rogers EVP and Chief Financial Officer (781) ...

Indevus Pharmaceuticals to Present at Upcoming Investor Conferences

... NEBIDO(R) for male hypogonadism, PRO 2000 for the prevention of infection by HIV and other sexually-transmitted pathogens, the octreotide implant for acromegaly and carcinoid syndrome, and pagoclone for stuttering. Forward Looking Statements Except for the descriptions of historical facts contained ...

Indevus and FDA Agree on Path Forward for NEBIDO(R)

... for male hypogonadism, PRO 2000 for the prevention of infection by HIV and other sexually-transmitted pathogens, and the octreotide implant for acromegaly and carcinoid syndrome. Forward Looking Statements Except for the descriptions of historical facts contained herein, this press release contains ...

Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After Surgery

... chronic myelogenous leukemia (Ph+ CML) and five other rare diseases. Novartis also has a therapy for the treatment of carcinoid tumors and acromegaly and multiple treatments in the pipeline targeting rare diseases. Filing data The study on which the regulatory filing is based compared ...

Indevus Announces Private Placement of $105 Million of Non-Recourse Notes

... for male hypogonadism, PRO 2000 for the prevention of infection by HIV and other sexually-transmitted pathogens, and the octreotide implant for acromegaly and carcinoid syndrome. Forward Looking Statements Except for the descriptions of historical facts contained herein, this press release contains ...
Acromegaly in Biological Dictionary

Pituitary gland

... the pituitary gland produces growth hormone for normal development ... PNA Disorders Section - Introduction to the Pituitary Gland . acromegaly ... Structurally, the pituitary gland is divided into a larger anterior region ... pituitary gland n. A small oval endocrine gland ...
Other Contents
(Date:9/30/2014)... partnership funded by the Department of Defense (DoD) ... better-run clinical trials and may lead to the ... condition affecting not only athletes and soldiers, but ... youngsters to elders. , Under the partnership, ... million, five-year award from the DoD, the research ...
(Date:9/30/2014)... IL (PRWEB) September 30, 2014 Healthcare ... at the National Association of Health Advocacy Consultants (#NAHAC) ... Healthcare Advocacy” (#NAHAC14) to be held October 30th - ... its debut at NAHAC14: Standards and Best Practices for ... grows into a profession, advocates have needed a set ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 Life Length ... provides CHL access to Life Length’s proprietary Telomere Analysis ... and comprehensive telomere test on the market today, and ... the percentage of short telomeres, providing the most critical ... Chairman of the Department of Cell Biology at The ...
(Date:9/30/2014)... 2014 Market Research Report on ... professional and in-depth market survey on Global and ... basic information of Cialis including its classification, application ... and China’s top manufacturers of Cialis listing their ... etc. , The report further analyzes quantitatively 2009-2014 ...
(Date:9/30/2014)... 30, 2014 Catalent Pharma Solutions ... delivery technologies and development solutions for drugs, biologics ... agenda for the 25th Annual CPhI Worldwide Exhibition ... 6th to 9th. , Catalent is showcasing a ... during the show, including its facilities in China ...
Breaking Medicine News(10 mins):Health News:US aims for traumatic brain injury clinical trial success 2Health News:US aims for traumatic brain injury clinical trial success 3Health News:US aims for traumatic brain injury clinical trial success 4Health News:Life Length® Announces New Partnership with Cleveland HeartLab® to Offer Telomere Technology in North America 2Health News:Life Length® Announces New Partnership with Cleveland HeartLab® to Offer Telomere Technology in North America 3Health News:Cialis Industry (CAS 171596-29-5) Global and Chinese Analysis for 2014-2019 Now Available at LifeScienceIndustryResearch.com 2Health News:Cialis Industry (CAS 171596-29-5) Global and Chinese Analysis for 2014-2019 Now Available at LifeScienceIndustryResearch.com 3Health News:Cialis Industry (CAS 171596-29-5) Global and Chinese Analysis for 2014-2019 Now Available at LifeScienceIndustryResearch.com 4Health News:Catalent Showcases Advanced Technologies and Supply Capabilities at CPhI Worldwide Conference and Exhibition 2Health News:Catalent Showcases Advanced Technologies and Supply Capabilities at CPhI Worldwide Conference and Exhibition 3
(Date:9/30/2014)... in German . ... to risky situations such as exposure to predators. Researchers ... in a long-term study on different populations of great ... and ambient temperature. High metabolic rates and low temperatures ... scenarios birds were more likely to approach potential predators. ...
(Date:9/30/2014)... perilous threats in today,s ocean. From overfishing and ... coral ecosystems are disappearing at unprecedented rates around ... corals surrounding the island of Moorea in French ... environment: coral guard-crabs. New research from the National ... Seabird McKeon and the museum,s predoctoral fellow Jenna ...
(Date:9/30/2014)... HONG KONG , Sept. 30, 2014 Winners of ... The Economist Events, Innovation Summit scheduled to take place at the ... At the summit, the award winners will share their experiences and ... people who have made a proven innovation over the past decade, ... the night before the summit. It will be the ...
Breaking Biology News(10 mins):Risky metabolism 2Smithsonian scientists discover coral's best defender against an army of sea stars 2Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 2Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 3Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 4Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 5Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 6Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 7
Other TagsOther Tags